Yi Fan Selected Research

isogambogenic acid

4/2020	Author Correction: Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells.
1/2015	Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells.
10/2013	Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Fan Research Topics

Disease

48	Neoplasms (Cancer) 09/2022 - 05/2007
10	Parkinson Disease (Parkinson's Disease) 12/2021 - 06/2011
9	Infections 03/2021 - 02/2004
7	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 05/2014
7	Hypoxia (Hypoxemia) 03/2020 - 11/2003
6	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2010
6	Neuroinflammatory Diseases 12/2021 - 01/2016
5	Carcinogenesis 01/2022 - 05/2014
5	Inflammation (Inflammations) 12/2021 - 04/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2016
4	Myocardial Infarction 11/2021 - 07/2014
4	Fibrosis (Cirrhosis) 11/2017 - 01/2011
3	Hemorrhage 04/2022 - 07/2021
3	Wounds and Injuries (Trauma) 04/2022 - 09/2012
3	Mouth Neoplasms (Oral Cancer) 01/2022 - 01/2022
3	Osteoarthritis 12/2021 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
3	Ischemia 01/2020 - 01/2017
3	Hyperplasia 01/2018 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 03/2015 - 05/2010
2	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 01/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2021
2	Diarrhea 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Cystitis 01/2021 - 01/2021
2	Pain (Aches) 01/2021 - 01/2021
2	Hyperalgesia 01/2021 - 01/2021
2	Hepatitis B 01/2021 - 06/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2017
2	Virus Diseases (Viral Diseases) 11/2019 - 06/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2018 - 01/2017
2	Triple Negative Breast Neoplasms 01/2018 - 01/2016
2	Glioma (Gliomas) 01/2018 - 09/2015
2	Hypercalciuria 01/2017 - 01/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 01/2007
2	Brain Diseases (Brain Disorder) 05/2014 - 05/2012
2	Chronic Hepatitis B 04/2014 - 04/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012 - 01/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022
1	Kidney Calculi (Kidney Stone) 04/2022
1	Leukemia 04/2022
1	Cytokine Release Syndrome 02/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
10	Pharmaceutical PreparationsIBA 01/2022 - 05/2010
9	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2015
7	Messenger RNA (mRNA)IBA 01/2022 - 09/2012
7	RNA (Ribonucleic Acid)IBA 10/2021 - 05/2007
6	CytokinesIBA 01/2022 - 01/2011
6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2021 - 06/2011
5	Long Noncoding RNAIBA 01/2022 - 10/2015
5	SynucleinsIBA 12/2021 - 12/2017
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 02/2015
5	VaccinesIBA 12/2020 - 11/2016
4	Interleukin-6 (Interleukin 6)IBA 02/2022 - 01/2017
4	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2007
4	AntigensIBA 01/2021 - 09/2017
4	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 01/2011
3	IronIBA 01/2022 - 01/2012
3	isogambogenic acidIBA 04/2020 - 10/2013
3	Biological ProductsIBA 04/2018 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2012
3	Aquaporins (Water Channels)IBA 05/2014 - 08/2008
3	Adenosine Triphosphate (ATP)IBA 12/2012 - 11/2003
2	Chimeric Antigen ReceptorsIBA 02/2022 - 01/2021
2	LigandsIBA 01/2022 - 12/2021
2	CollagenIBA 01/2022 - 12/2021
2	InflammasomesIBA 12/2021 - 07/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 04/2014
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 01/2017
2	Parathyroid Hormone-Related ProteinIBA 01/2021 - 01/2017
2	hepatitis B hyperimmune globulinIBA 01/2021 - 02/2004
2	Phosphotransferases (Kinase)IBA 12/2020 - 05/2015
2	CateninsIBA 01/2020 - 01/2017
2	PlasminogenIBA 01/2020 - 07/2014
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2016
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2018 - 01/2018
2	Parathyroid Hormone (Parathormone)IBA 01/2018 - 01/2016
2	Calcitriol (Calcijex)FDA LinkGeneric 11/2017 - 04/2017
2	Peptides (Polypeptides)IBA 01/2017 - 01/2017
2	CalciumIBA 01/2017 - 01/2016
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 01/2015
2	LipopolysaccharidesIBA 01/2016 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 09/2012
2	SaltsIBA 11/2013 - 01/2007
1	Hemostatics (Antihemorrhagics)IBA 04/2022
1	ApoferritinsIBA 02/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022

Therapy/Procedure

21	Therapeutics 02/2022 - 03/2012
5	Immunotherapy 12/2021 - 01/2021
5	Radiotherapy 01/2019 - 03/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
3	Brachytherapy 09/2022 - 11/2015
2	Castration 01/2022 - 01/2016
2	Stem Cell Transplantation 01/2021 - 01/2018
2	Aftercare (After-Treatment) 03/2015 - 05/2010
1	Surgical Instruments (Clip) 04/2022